Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Increased risks of developing anxiety and depression in young patients with Crohn's disease.

Loftus EV Jr, Guérin A, Yu AP, Wu EQ, Yang M, Chao J, Mulani PM.

Am J Gastroenterol. 2011 Sep;106(9):1670-7. doi: 10.1038/ajg.2011.142. Epub 2011 May 3.

PMID:
21537359
2.

Risks of developing psychiatric disorders in pediatric patients with psoriasis.

Kimball AB, Wu EQ, Guérin A, Yu AP, Tsaneva M, Gupta SR, Bao Y, Mulani PM.

J Am Acad Dermatol. 2012 Oct;67(4):651-7.e1-2. doi: 10.1016/j.jaad.2011.11.948. Epub 2012 Jan 13.

PMID:
22243764
3.

Depression and anxiety in people with inflammatory bowel disease.

Kurina LM, Goldacre MJ, Yeates D, Gill LE.

J Epidemiol Community Health. 2001 Oct;55(10):716-20.

4.

Anxiety and depression in patients with inflammatory bowel disease: comparisons with chronic liver disease patients and the general population.

Häuser W, Janke KH, Klump B, Hinz A.

Inflamm Bowel Dis. 2011 Feb;17(2):621-32. doi: 10.1002/ibd.21346.

PMID:
20848528
5.

Psychological distress in Brazilian Crohn's disease patients: screening, prevalence, and risk factors.

Brandi MT, Ribeiro MS, Chebli LA, Franco MB, Pinto AL, Gaburri PD, Zanini A, Chebli JM.

Med Sci Monit. 2009 Aug;15(8):PH101-8.

PMID:
19644430
6.

Patient characteristics and prescription fill patterns for allergic rhinitis medications, with a focus on montelukast, in a commercially insured population.

Bollinger ME, Diette GB, Chang CL, Stephenson JJ, Sajjan SG, Fan T, Allen-Ramey FC.

Clin Ther. 2010 Jun;32(6):1093-102. doi: 10.1016/j.clinthera.2010.06.003.

PMID:
20637964
7.

Asthma and depressive and anxiety disorders among young persons in the community.

Goodwin RD, Fergusson DM, Horwood LJ.

Psychol Med. 2004 Nov;34(8):1465-74.

PMID:
15724877
8.

Crohn's disease over 20 years after diagnosis in a referral population.

Etienney I, Bouhnik Y, Gendre JP, Lémann M, Cosnes J, Matuchansky C, Beaugerie L, Modigliani R, Rambaud JC.

Gastroenterol Clin Biol. 2004 Dec;28(12):1233-9.

9.

Mood and nonmood components of perceived stress and exacerbation of Crohn's disease.

Cámara RJ, Schoepfer AM, Pittet V, Begré S, von Känel R; Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS) Group.

Inflamm Bowel Dis. 2011 Nov;17(11):2358-65. doi: 10.1002/ibd.21623. Epub 2011 Feb 1.

PMID:
21287671
10.

Overlap of anxiety and depression in a managed care population: Prevalence and association with resource utilization.

McLaughlin TP, Khandker RK, Kruzikas DT, Tummala R.

J Clin Psychiatry. 2006 Aug;67(8):1187-93.

PMID:
16965195
11.

Psychological impact of Crohn's disease on patients in remission: anxiety and depression risks.

Iglesias M, Barreiro de Acosta M, Vázquez I, Figueiras A, Nieto L, Lorenzo A, Domínguez-Muñoz JE.

Rev Esp Enferm Dig. 2009 Apr;101(4):249-57. English, Spanish.

12.

Depressive disorder in renal transplantation: an analysis of Medicare claims.

Dobbels F, Skeans MA, Snyder JJ, Tuomari AV, Maclean JR, Kasiske BL.

Am J Kidney Dis. 2008 May;51(5):819-28. doi: 10.1053/j.ajkd.2008.01.010. Epub 2008 Mar 20.

PMID:
18436093
13.

Long-term fracture risk in patients with Crohn's disease: a population-based study in Olmsted County, Minnesota.

Loftus EV Jr, Crowson CS, Sandborn WJ, Tremaine WJ, O'Fallon WM, Melton LJ 3rd.

Gastroenterology. 2002 Aug;123(2):468-75.

PMID:
12145800
14.

The impact of major depressive disorder on the short- and long-term outcome of Crohn's disease treatment with infliximab.

Persoons P, Vermeire S, Demyttenaere K, Fischler B, Vandenberghe J, Van Oudenhove L, Pierik M, Hlavaty T, Van Assche G, Noman M, Rutgeerts P.

Aliment Pharmacol Ther. 2005 Jul 15;22(2):101-10.

15.

National trends in psychotropic medication polypharmacy in office-based psychiatry.

Mojtabai R, Olfson M.

Arch Gen Psychiatry. 2010 Jan;67(1):26-36. doi: 10.1001/archgenpsychiatry.2009.175.

PMID:
20048220
17.

Inflammatory bowel disease in children and adolescents: a somatic and psychiatric investigation.

Engström I, Lindquist BL.

Acta Paediatr Scand. 1991 Jun-Jul;80(6-7):640-7.

PMID:
1867081
18.

Anxiety, depression and psychotropic medication use in patients with persistent upper and lower gastrointestinal symptoms.

van Kerkhoven LA, van Rossum LG, van Oijen MG, Witteman EM, Jansen JB, Laheij RJ, Tan AC.

Aliment Pharmacol Ther. 2005 Apr 15;21(8):1001-6.

19.

Depressive and anxiety disorders and risk of subclinical atherosclerosis Findings from the Netherlands Study of Depression and Anxiety (NESDA).

Seldenrijk A, Vogelzangs N, van Hout HP, van Marwijk HW, Diamant M, Penninx BW.

J Psychosom Res. 2010 Aug;69(2):203-10. doi: 10.1016/j.jpsychores.2010.01.005. Epub 2010 Mar 19.

PMID:
20624520
20.

Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.

Morrato EH, Dodd S, Oderda G, Haxby DG, Allen R, Valuck RJ.

Clin Ther. 2007 Jan;29(1):183-95.

PMID:
17379060

Supplemental Content

Support Center